Evelyne Schaller

Person

Munich, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Cross-species-specific PSMAxCD3 bispecific single chain antibody
- Patent number 11,472,886
- Issue date Oct 18, 2022
- Amgen Research (Munich) GmbH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical compositions with resistance to soluble CEA
- Patent number 9,982,063
- Issue date May 29, 2018
- Amgen Research (Munich) GmbH
- Ralf Lutterbüse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions with resistance to soluble CEA
- Patent number 9,695,250
- Issue date Jul 4, 2017
- Amgen Research (Munich) GmbH
- Ralf Lutterbüse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cross-species-specific PSMAxCD3 bispecific single chain antibody
- Patent number 9,587,036
- Issue date Mar 7, 2017
- Amgen Research (Munich) GmbH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical compositions with resistance to soluble CEA
- Patent number 8,394,926
- Issue date Mar 12, 2013
- Micromet AG
- Ralf Lutterbüse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20230037742
- Publication date Feb 9, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Peter KUFER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20210277143
- Publication date Sep 9, 2021
- AMGEN RESEARCH (MUNICH) GMBH
- Peter KUFER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20210269550
- Publication date Sep 2, 2021
- AMGEN RESEARCH (MUNICH) GMBH
- Peter KUFER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20190169310
- Publication date Jun 6, 2019
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS WITH RESISTANCE TO SOLUBLE CEA
- Publication number 20170137538
- Publication date May 18, 2017
- AMGEN RESEARCH (MUNICH) GMBH
- Ralf Lutterbüse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS WITH RESISTANCE TO SOLUBLE CEA
- Publication number 20130273050
- Publication date Oct 17, 2013
- Ralf LUTTERBÜSE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20130129730
- Publication date May 23, 2013
- Amgen Research (Munich) GmbH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMPOSITIONS WITH RESISTANCE TO SOLUBLE CEA
- Publication number 20090226432
- Publication date Sep 10, 2009
- Micromet AG
- Ralf Lutterbüse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Evelyne Schaller

Person

Patents Grantslast 30 patents

Cross-species-specific PSMAxCD3 bispecific single chain antibody

Pharmaceutical compositions with resistance to soluble CEA

Pharmaceutical compositions with resistance to soluble CEA

Cross-species-specific PSMAxCD3 bispecific single chain antibody

Pharmaceutical compositions with resistance to soluble CEA

Patents Applicationslast 30 patents

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

PHARMACEUTICAL COMPOSITIONS WITH RESISTANCE TO SOLUBLE CEA

PHARMACEUTICAL COMPOSITIONS WITH RESISTANCE TO SOLUBLE CEA

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

PHARMACEUTICAL COMPOSITIONS WITH RESISTANCE TO SOLUBLE CEA